Cargando…

Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation

BACKGROUND: Oral anticoagulants (OAC) is indicated for stroke prevention in patients with atrial fibrillation (AF) with a moderate or high risk of stroke. Despite the benefits of stroke prevention, only 50%-60% of Americans with nonvalvular AF and a moderate or high risk of stroke receive OAC medica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jingchuan Serena, He, Meiqi, Gabriel, Nico, Magnani, Jared W, Kimmel, Stephen E, Gellad, Walid F, Hernandez, Inmaculada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276659/ https://www.ncbi.nlm.nih.gov/pubmed/36427343 http://dx.doi.org/10.18553/jmcp.2022.28.12.1400

Ejemplares similares

COVID‐19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data
por: Hernandez, Inmaculada, et al.
Publicado: (2021)

COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data
por: Hernandez, Inmaculada, et al.
Publicado: (2023)

Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysis
por: Hernandez, Inmaculada, et al.
Publicado: (2022)

Effective and underprescribed: what about clozapine?
por: Müller, Helge H. O.
Publicado: (2017)

Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation
por: Yang, Lanting, et al.
Publicado: (2021)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
por: Hernandez, Inmaculada, et al.
Publicado: (2019)

Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation
por: Guo, Jingchuan, et al.
Publicado: (2021)

COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data
por: He, Meiqi, et al.
Publicado: (2022)

Underfilling decreases left ventricular function in pulmonary arterial hypertension
por: Sjögren, Hannah, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries
por: Hernandez, Inmaculada, et al.
Publicado: (2021)

Left ventricular underfilling in PAH: A potential indicator for adaptive‐to‐maladaptive transition
por: Guo, Jiajun, et al.
Publicado: (2023)

Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
por: Essien, Utibe R., et al.
Publicado: (2021)

Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans
por: Newman, Terri Victoria, et al.
Publicado: (2022)

Capillary Underfill Flow Simulation as a Design Tool for Flow-Optimized Encapsulation in Heterogenous Integration †
por: Stencel, Lisa Christin, et al.
Publicado: (2023)

Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019
por: Dickson, Sean, et al.
Publicado: (2023)

Highly Thermally Conductive Epoxy Composites with AlN/BN Hybrid Filler as Underfill Encapsulation Material for Electronic Packaging
por: Lee Sanchez, William Anderson, et al.
Publicado: (2022)

Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019
por: Dickson, Sean R., et al.
Publicado: (2023)

Enhanced Thermal Conductivity of Epoxy Composites Filled with Al(2)O(3)/Boron Nitride Hybrids for Underfill Encapsulation Materials
por: Lee Sanchez, William Anderson, et al.
Publicado: (2021)

Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer
por: Hernandez, Inmaculada, et al.
Publicado: (2020)

Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study
por: Wilkinson, Chris, et al.
Publicado: (2020)

Area Deprivation Index and Oral Anticoagulation in New Onset Atrial Fibrillation
por: Omole, Toluwa D., et al.
Publicado: (2022)

Effect of Wafer Level Underfill on the Microbump Reliability of Ultrathin-Chip Stacking Type 3D-IC Assembly during Thermal Cycling Tests
por: Lee, Chang-Chun
Publicado: (2017)

Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis
por: Wilkinson, Chris, et al.
Publicado: (2022)

Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy
por: Stephenson, Judith J, et al.
Publicado: (2018)

Identifying Patients at Risk of Acute Kidney Injury Among Medicare Beneficiaries With Type 2 Diabetes Initiating SGLT2 Inhibitors: A Machine Learning Approach
por: Yang, Lanting, et al.
Publicado: (2022)

Risks and benefits of oral anticoagulants for stroke prophylaxis in atrial fibrillation according to body mass index: Nationwide cohort study of primary care records in England
por: Nakao, Yoko M., et al.
Publicado: (2022)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics
por: Lehto, Mika, et al.
Publicado: (2022)

Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study
por: Højen, Anette Arbjerg, et al.
Publicado: (2022)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022)

Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation
por: Saliba, Walid
Publicado: (2015)

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
por: AbuDagga, Azza, et al.
Publicado: (2014)

LHC claims energy world record
Publicado: (2009)

Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19
por: Hernandez, Inmaculada, et al.
Publicado: (2021)

Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020
por: Hernandez, Inmaculada, et al.
Publicado: (2021)

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset
por: Mueller, Sabrina, et al.
Publicado: (2018)

Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
por: El Kadri, Moutaz, et al.
Publicado: (2021)

Use of Oral Anticoagulation Therapy in Atrial Fibrillation after Stroke: Results from a Nationwide Registry
por: Jespersen, Stine Funder, et al.
Publicado: (2013)

Sex Differences in Oral Anticoagulation Therapy in Patients Hospitalized With Atrial Fibrillation: A Nationwide Cohort Study
por: Lee, Kuan Ken, et al.
Publicado: (2023)

Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020
por: Dickson, Sean, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5tpjfqsmo237chhtib46pbitvs